Physician profile
Eden Tedla
NPI 1013437342
$8,888.04
in general payments reported to CMS, 2019-2025
23 companies · $733 in 2025
The $733 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,315 · 2022: $2,302 · 2023: $2,063 · 2024: $1,475 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,271.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,355.31 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,083.31 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Abbvie INC. | $981.22 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $911.03 | 2021-2024 | Lokelma, Fasenra, Farxiga |
| Novartis Pharmaceuticals Corporation | $719.46 | 2021-2024 | |
| Gilead Sciences, INC. | $658.65 | 2021-2024 | Veklury |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $550.40 | 2022-2025 | Xifaxan |
| Pfizer INC. | $448.44 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $345.82 | 2021-2024 | Nuzyra |
| Alnylam Pharmaceuticals INC. | $291.12 | 2022-2025 | Givlaari |
| Merck Sharp & Dohme LLC | $288.85 | 2021-2025 | Dificid, Zerbaxa, Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $269.12 | 2021-2025 | Lifevest |
| Melinta Therapeutics, LLC | $242.43 | 2021-2022 | |
| Boston Scientific Corporation | $229.47 | 2021-2024 | Watchman Flx, Watchman Access System |
| Alexion Pharmaceuticals, INC. | $146.64 | 2022-2023 | Ultomiris |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $144.13 | 2021-2022 | |
| Electromed, INC. | $61.88 | 2022-2024 | Smartvest |
| Bioxcel Therapeutics, INC. | $52.44 | 2023 | Igalmi |
| Inari Medical, INC. | $28.06 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cmp Pharma, INC. | $23.16 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.36 | 2025 | |
| Glaxosmithkline, LLC. | $20.02 | 2025 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $15.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eden Tedla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.